Best Practices for Modernizing Specialty PA Workflows

Very few specialty practices sat down and designed their prior authorization process. Rather, it accumulated. A step was added when a payer changed a rule. A workaround stuck because it solved a problem during a busy week. A habit formed around a fax machine and never got revisited. Layer by layer, the prior authorization process for specialty medications took shape, and most of it still runs on decisions no one consciously made.

This organic process usually works well enough. But it also carries dead weight: redundant steps, unclear ownership, and manual routines that made sense years ago and haven’t been questioned since. That’s where preventable delays and denials live.

Most practices need to overhaul their prior authorization workflow, and that takes more than new technology. It requires replacing inherited habits with intentional clinical and administrative workflow design. Let’s look at where those habits typically hide, and what a more intentional approach to each stage looks like in practice.

From Generic Checklists to Payer-Specific Documentation

The most common inherited habit in the prior authorization process for specialty medications is the universal checklist: one documentation list applied to every submission, regardless of payer, plan, or drug class. It feels efficient, but it quietly manufactures denials.

The modern approach replaces it with payer-specific documentation assembly as a defined pre-submission stage. Someone following an old habit pulls clinical documentation reactively, chasing a note or a lab mid-submission while the clock runs.  A more intentional process has the relevant pieces already in hand before a request goes out: diagnosis confirmation, step therapy and fail-first history, lab results tied to the specific drug class, and prescriber notes that establish medical necessity criteria for specialty drugs on the payer’s terms. In the specialty PA workflow framework, this starts at Intake—get it right there, and the rest of the process stops fighting itself.

Successful PA workflow transitions hinge on timing. Every handoff between administrative and clinical staff is a delay point, and reducing those handoffs is one of the highest-leverage moves a specialty practice can make. National data backs the urgency, with 91% of specialty providers reporting treatment delays tied to prior authorization and more than half facing delays averaging five days or longer. Much of that gap opens while a request waits on documentation that could have been ready from the start.

What the Major Insurers Are Actually Looking For

Modernizing documentation starts with knowing what you’re building toward. Prior authorization documentation requirements vary by payer, but the categories that appear most consistently are predictable. The chart below is a starting baseline. (Payer-specific prior authorization requirements shift by drug class and plan, so treat it as a reference to adapt rather than a rule to memorize.)

Documentation Type	Commercial	Medicare Advantage	Medicaid
Diagnosis confirmation (ICD-10 + date)	Required	Required	Required
Step therapy / fail-first history	Usually required	Often required	Frequently required, often stricter sequencing
Drug-class lab results	Required	Required	Required
Prescriber medical-necessity notes	Required	Tied to plan coverage criteria	Tied to state criteria
Payer/plan-specific forms	Plan-specific	Plan rules + CMS	State-specific

A few patterns are worth noting. Step therapy documentation for specialty medications and fail-first history tend to be the most variable, with Medicaid plans often applying the strictest sequencing. Lab requirements are driven more by drug class than payer: a TB screen before a biologic, disease-activity markers for inflammatory conditions, diagnostic or genetic confirmation for rare-disease therapies. Prescriber notes carry the most weight when they map explicitly to the payer’s published medical necessity criteria rather than restating the diagnosis. Pharmaceutical support programs often publish their own checklists for specific products, which can be a useful cross-reference when building your baseline and, ultimately, for prior authorization turnaround time improvement. 

From Fax-and-Follow-Up to Electronic Submission With a Defined Cadence

The second inherited habit relates to how requests leave the building and how they’re tracked once they do. The default in many practices is still fax when a portal exists, status checks whenever someone finds a free moment, and ownership of active authorizations spread informally across whoever is around.

The modern version changes three things: electronic submission wherever the payer supports it, a defined follow-up cadence with specific intervals instead of ad hoc checking, and clear ownership for every active authorization so nothing sits unwatched.

None of this optimization requires new software to begin. These are process disciplines first. For example, a practice can define a cadence and name an owner for each request today with the tools it already has. Technology makes the disciplines easier to sustain at volume, but it doesn’t replace the decision to adopt them.

A notable case for shifting workflows is volume. Practices now complete an average of 43 prior authorizations per physician each week. At that scale, manual follow-up can break the entire process. It’s no surprise that 92% of medical practices have had to hire or redistribute staff to keep up with prior authorization demand. Electronic prior authorization submission and a structured cadence are how a practice absorbs that volume without taking on proportional cost.

There’s a transparency tailwind here too. New state laws increasingly require plans to categorize and publish their denial reasons by medication and physician specialty. Practices that build intentional workflows now will be better positioned to act on that data than those still running on inherited habits.

Keep the Specialty Medication Prior Authorization Process Current

Prior authorization optimization doesn’t end at implementation. Payer requirements change, new therapies arrive, and rules that were current last quarter quietly expire. The practices that hold high approval rates and fast turnaround times treat their process standards as living documents, revisiting them on a schedule rather than after a wave of denials forces the issue.

CareTria Provider Connect is built for exactly this kind of deliberate operation. It automates documentation assembly, supports electronic prior authorization submission across more than 1,400 payers, and provides real-time status tracking, turning the before-and-after transitions above into how the work runs by default.

See how CareTria Provider Connect modernizes the prior authorization process for specialty medications.

FAQs About Specialty PA Workflows

What does it mean to “modernize” a specialty PA workflow?

It means replacing inherited manual habits with deliberate clinical and administrative workflow design. Instead of applying a generic checklist and chasing documentation mid-submission, a modern workflow assembles payer-specific documentation before submitting, submits electronically where possible, and follows up on a defined schedule.

Do we need new software to modernize our prior authorization process for specialty medications?

No. The core changes are process disciplines. You can assign clear ownership for each authorization, build a follow-up cadence, and standardize payer-specific documentation with the tools you already have. Technology makes those disciplines easier to sustain at volume, but the decision to adopt them comes first.

Why does payer-specific documentation matter so much?

Because commercial, Medicare Advantage, and Medicaid plans ask for different things, and requirements shift by drug class. A single generic checklist almost guarantees gaps for some payers. Assembling documentation around each payer’s actual criteria removes a common, avoidable source of denials.

What’s the fastest way to improve turnaround time?

Front-load documentation at intake and submit electronically where available. Most delays accumulate while a request waits on a lab result or note that could have been ready before submission, or sits unwatched because no one owns follow-up. Fixing those two points usually improves turnaround more than anything else.

How often should we revisit our PA process?

On a set schedule, not just after a denial spike. Payer requirements change throughout the year. High-performing practices review their documentation standards and payer requirements regularly, so their process reflects current rules rather than last year’s.